scholarly article | Q13442814 |
P50 | author | Jasjit Ahluwalia | Q60055425 |
P2093 | author name string | Won S Choi | |
Robert M McCool | |||
Kimber P Richter | |||
Kari J Harris | |||
P433 | issue | 11 | |
P304 | page(s) | 1258-1264 | |
P577 | publication date | 2004-11-01 | |
P1433 | published in | Psychiatric Services | Q7256227 |
P1476 | title | Smoking cessation services in U.S. methadone maintenance facilities | |
P478 | volume | 55 |
Q36642474 | A Pilot Study of a Readiness Group to Increase Initiation of Smoking Cessation Services among Women in Residential Addiction Treatment |
Q47606772 | A cross-sectional analysis of factors associated with the intention to engage in tobacco treatment among inpatients in a state psychiatric hospital. |
Q36912594 | A quasi-experimental study examining New York State's tobacco-free regulation: effects on clinical practice behaviors. |
Q35017325 | A rationale and model for addressing tobacco dependence in substance abuse treatment |
Q89928410 | Achieving Smoking Cessation Among Persons with Opioid Use Disorder |
Q35909531 | Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settings. |
Q33629806 | Addressing tobacco in Australian alcohol and other drug treatment settings: a cross-sectional survey of staff attitudes and perceived barriers |
Q33781918 | Adherence to methadone maintenance treatment and associated factors among patients in Vietnamese mountainside areas |
Q49314015 | Alcohol and tobacco use among methadone maintenance patients in Vietnamese rural mountainside areas. |
Q37187104 | An international systematic review of smoking prevalence in addiction treatment |
Q35147373 | Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuation |
Q35975307 | Barriers to Telephone Quitline Use Among Methadone-Maintained Smokers |
Q30202808 | Behavioral Healthcare Staff Attitudes and Practices Regarding Consumer Tobacco Cessation Services |
Q87259101 | Capacity of US drug treatment facilities to provide evidence-based tobacco treatment |
Q37341497 | Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalities |
Q35553975 | Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study |
Q37373872 | Cigarette smoking among opioid-dependent clients in a therapeutic community |
Q36946388 | Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States |
Q37619870 | Climate for innovation, 12-step orientation, and tobacco cessation treatment |
Q37011843 | Commentary on Szatkowski & McNeill (2013): Where the smokers are. |
Q40451688 | Commitment and capacity for providing evidence-based tobacco treatment in US drug treatment facilities. |
Q89149140 | Considering Systemic Barriers to Treating Tobacco Use in Clinical Settings in the United States |
Q35092020 | Contingency management for behavior change: applications to promote brief smoking cessation among opioid-maintained patients |
Q37250251 | Correlates of heavy smoking among alcohol-using methadone maintenance clients |
Q37632330 | Counselor and clinical supervisor perceptions of OASAS tobacco-free regulation implementation extensiveness, perceived accountability, and use of resources |
Q36283095 | Determining Smoking Cessation Related Information, Motivation, and Behavioral Skills among Opiate Dependent Smokers in Methadone Treatment |
Q34066720 | Development of the Smoking Knowledge, Attitudes, and Practices (S-KAP) Instrument |
Q34967022 | Differences in Substance Abuse Counselors' Knowledge of Tobacco Cessation Medication Effectiveness: 2002-2008. |
Q91624743 | Electronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment |
Q34111054 | Facilitating Factors and Barriers to the Use of Medications in Publicly Funded Addiction Treatment Organizations |
Q38674919 | Factors associated with nicotine dependence during methadone maintenance treatment: findings from a multisite survey in Vietnam |
Q37072555 | Feasibility of promoting smoking cessation among methadone users using multimedia computer-assisted education |
Q36460342 | Going tobacco-free: predictors of clinician reactions and outcomes of the NY State Office of Alcoholism and Substance Abuse Services tobacco-free regulation |
Q35570838 | How is tobacco treatment provided during drug treatment? |
Q38868326 | Implementation of smoking cessation treatment in substance use disorder treatment settings: a review |
Q37145902 | Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness |
Q35417708 | Marijuana use and tobacco smoking cessation among heavy alcohol drinkers |
Q34709097 | Measuring smoking knowledge, attitudes and services (S-KAS) among clients in addiction treatment |
Q33984533 | Medical and Mental Health Status Among Drug Dependent Patients Participating in a Smoking Cessation Treatment Study |
Q58131549 | Missed opportunities to test the neuropsychiatric safety--and efficacy--of varenicline among smokers with substance use disorders |
Q42860392 | Nicotine dependence and depression among women smokers on methadone maintenance |
Q37724929 | Organizational factors as predictors of tobacco cessation pharmacotherapy adoption in addiction treatment programs. |
Q36496900 | Predictors of dropout from group therapy among patients with bipolar and substance use disorders |
Q34778712 | Profiting and providing less care: comprehensive services at for-profit, nonprofit, and public opioid treatment programs in the United States |
Q36291920 | Psychological Barriers to Tobacco Cessation in Indian Buprenorphine-Naloxone Maintained Patients: A Pilot Study |
Q34528070 | Smoking Cessation Services in Adolescent Substance Abuse Treatment: Opportunities Missed? |
Q34334331 | Smoking among adolescents in substance abuse treatment: a study of programs, policy, and prevalence |
Q37159031 | Smoking and opioid detoxification: behavioral changes and response to treatment. |
Q48022741 | Smoking cessation among Australian methadone clients: prevalence, characteristics and a need for action |
Q33923700 | Smoking cessation treatment among office-based buprenorphine treatment patients |
Q35012377 | Smoking prevalence in addiction treatment: a review |
Q33967949 | Staff Knowledge, Attitudes, and Practices Regarding Nicotine Dependence Differ by Setting |
Q34267724 | Staff commitment to providing tobacco dependence in drug treatment: Reliability, validity, and results of a national survey |
Q34357565 | Staff smoking and other barriers to nicotine dependence intervention in addiction treatment settings: a review |
Q34070104 | Structural and cultural barriers to the adoption of smoking cessation services in addiction treatment organizations |
Q34245034 | Substance Abuse Treatment Counselors and Tobacco Use: A Comparison of Comprehensive and Indoor-Only Workplace Smoking Bans |
Q36966583 | Substance abuse counselors' implementation of tobacco cessation guidelines |
Q36823244 | Sustainment of smoking cessation programs in substance use disorder treatment organizations |
Q52300494 | The New York policy on smoking in addiction treatment: findings after 1 year. |
Q88551439 | The Untreated Addiction: Going Tobacco-Free in a VA Substance Abuse Residential Rehabilitation Treatment Program (SARRTP) |
Q35291386 | The implementation of smoking cessation counseling in substance abuse treatment |
Q33830328 | The implementation of tobacco-related brief interventions in substance abuse treatment: a national study of counselors |
Q36992541 | The index of tobacco treatment quality: development of a tool to assess evidence-based treatment in a national sample of drug treatment facilities |
Q30412259 | Understanding the drug treatment community's ambivalence towards tobacco use and treatment |
Q34992065 | Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial |
Search more.